Navigation Links
The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007
Date:3/3/2008

damage due to diabetic peripheral neuropathy. Conditions associated with diabetic peripheral neuropathy include numbness, skin ulcers, constant pain or extreme sensitivity to stimulus.

The research by the Company is part of its strategic initiatives to generate future growth. These initiatives include capitalizing on the growth potential of Quigley Pharma, a wholly owned Ethical Pharmaceutical subsidiary, by developing natural-source potential prescription products particularly for Diabetic Peripheral Neuropathy, Avian Flu in animals, Rheumatoid Arthritis and for protection against ionizing Radiation and other items.

The following is a summary of ethical pharmaceutical activities that occurred during 2007:

Diabetic Peripheral Neuropathy - QR-333: The number of enrolled subjects continue to increase in our Phase II(b) study designed to evaluate the safety and efficacy of the topical formulation on subjects with diabetic peripheral neuropathy. Subject screening and enrollment will continue to ensure at least a 140 evaluable patient study population. Once enrolled, subject treatment time is 12 weeks. To date the in-progress safety profile for this study has been consistent with favorable safety results of the previous human proof of concept study conducted in France.

Avian Flu Compound - QR-441(a): Positive results were achieved in a preliminary study which demonstrated the compound to be a potential antiviral agent for Infectious Bronchitis and New Castle Disease, two viral poultry diseases that have a significant annual economic impact on the poultry industry. Previous in vitro studies have demonstrated QR-441(a) to be a potent antiviral agent against H5N1 (Avian Flu).

In addition, an agreement was signed with the State of Israel Ministry of Agriculture & Rural Development (MOAG) and the Kimron Veterinary Institute to conduct a clinical trial testing the anti-viral capacity of the Quigley compound QR-441(a) administered as a medica
'/>"/>

SOURCE The Quigley Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. The Quigley Corporation Announces Sale of Its Health and Wellness Segment
2. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
3. Dialysis Corporation of America Announces Fiscal Year 2007 Earnings Release Date
4. Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results
5. National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008
6. Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games
7. Partners Center for Connected Health and EMC Corporation Launch New Web-Based Remote Monitoring Program to Help Employees Fight Hypertension
8. China Bionanometer Industries Corporation Announces New Products for China
9. Centene Corporation Unveils Winners of the 2008 Physician Summit Award
10. Dialysis Corporation of America Announces its Newest Center Opening in South Carolina
11. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... A decreased ability to identify odors might indicate ... while examinations of the eye could indicate the ... in the brain, according to the results of ... Association International Conference 2014 (AAIC 2014) in Copenhagen. ... ability to identify odors was significantly associated with ...
(Date:7/13/2014)... A Xarelto lawsuit webpage has ... provide consumers with the most current information regarding serious ... blood-thinning medication, as well as the growing number ... the country. The law firm is now offering free ... life-threatening internal bleeding and related complications while using Xarelto, ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Hope Palliative & ... monthly grief support group at the Tamarack Senior Living Community ... held at 10:30 A.M. on the 3rd Wednesdays of every ... 2014 at the Tamarack Community located at 55 S. Greeley ... bereaved individuals and there is no cost for the group. ...
(Date:7/13/2014)... According to the Living With KP book review ... that features a series of tips and advice on ... This guide consists of 14 chapters including:, ...     Chapter 2: What Cause KP? ,     Chapter 3: ...     Chapter 4: Keratosis Pilaris Treatment ,     Chapter ...
(Date:7/12/2014)... (PRWEB) July 13, 2014 Recently, Fadhits.com, a ... collection of elegant long graduation dresses to its ... promotion for its loyal clients. It wants to bring more ... items are now offered at discounted prices, up to 72% ... company is always working hard. Its online shop is a ...
Breaking Medicine News(10 mins):Health News:Smell and eye tests show potential to detect Alzheimer's early 2Health News:Smell and eye tests show potential to detect Alzheimer's early 3Health News:Smell and eye tests show potential to detect Alzheimer's early 4Health News:Smell and eye tests show potential to detect Alzheimer's early 5Health News:Smell and eye tests show potential to detect Alzheimer's early 6Health News:Smell and eye tests show potential to detect Alzheimer's early 7Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 2Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 4Health News:Hope Hospice Announces Grief Support Group at the Tamarack Senior Living Community 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2
... research finds that need for instant gratification might play a part ... keep their hands out of the cookie jar -- in other ... likely to be overweight as they get older. , ... stay away from enticing toys. , It,s unclear whether these ...
... (SEATTLE) The use of Avastin alone to treat ... it was safe and effective at delaying tumor progression, ... by a researcher at the Seattle Cancer Care Alliance., ... as alkylator-refractory anaplastic oligodendroglioma (AO), for which there is ...
... Partnership Promotes Equine Health and Wellness through Education ... Animal Health has joined forces as a leadership ... Safety and Integrity Alliance. The partnership,s aim is ... implemented through the new racetrack accreditation program are ...
... report finds , , MONDAY, April 6 (HealthDay News) -- The ... but researchers have now produced an overview of "light" smokers ... occasional smokers, which the U.S. Centers for Disease Control ... the country, is published in a series of studies and ...
... M. D. Anderson Cancer Center have discovered a gene that ... mutated in about half of all breast cancers. , The ... important in several other types of cancer, the team reports ... Causes for diminished PTEN protein levels in breast cancer absent ...
... new concept in senior care is sweeping the countryCORDOVA, Tenn., ... senior care franchise to combine practical and spiritual assistance, is ... be on April 8, 2009. The new office is located ... opening festivities will begin at 1:30 p.m. and will last ...
Cached Medicine News:Health News:Kids Who Lack Self-Control May Be Prone to Weight Gain 2Health News:Kids Who Lack Self-Control May Be Prone to Weight Gain 3Health News:Avastin effective at delaying brain tumor progression in recurrent disease 2Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 2Health News:Pfizer Animal Health Becomes Leadership Contributor to the NTRA Safety and Integrity Alliance 3Health News:Researchers Profile the 'Light' Smoker 2Health News:Gene helps protect tumor suppressor in breast cancer 2
(Date:7/13/2014)...  Eli Lilly and Company (NYSE: ... study in genetically engineered mice examining combination therapy ... N3pG and beta-secretase inhibitor BACE (LY2811376). Data results ... removing clumps of amyloid-beta protein in the brain ... to Alzheimer,s disease (AD) – than use of ...
(Date:7/11/2014)... 11, 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced ... for use in portable vaporizers, which contains CBD, ... in cannabis, cannabidiol offers consumers a THC-free product ... other vaporizer technology. Photo - ... 483 different compounds which are currently known, two ...
(Date:7/11/2014)... HILL, N.C. , July 11, 2014 /PRNewswire/ ... of pharmaceutical marketing and, consequently, organizations are turning ... for patients. As part of this ... it,s important to educate, communicate and engage patients ... disease awareness to patient empowerment. By mapping the ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... 21, 2011 ClinStar, LLC , an established ... Europe to the pharmaceutical and biotechnology industry, announced today ... Marcus Evans 6th Annual Clinical Research in Emerging ... (Logo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO ) The ...
... On the 1-year anniversary of Congress approving the District ... Patients, Cooperative (DCPC), a District-based non-profit organization and Safe ... Safe Access, will hold a press conference on Wednesday, ... John A. Wilson Building, 1350 Pennsylvania Ave. NW.   ...
Cached Medicine Technology:ClinStar to Present on Conducting Clinical Trials in Russia 2DC Patients' Cooperative to Announce Operations Hiatus Until City Shows Leadership 2
... 50 and 100 ms scans to perform truly ... and proprietary cardiac analysis software take full advantage ... x-ray detector rings to image the lumen of ... wall motion. The EBT C300 also supports traditional ...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right;) overall length 120mm; Stainless ...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right; ) overall length 120mm; Stainless ...
0.12 1x2 tips on a 2.5mm platform; Stainless Steel Tip; 32mm shaft; Titanium Handle....
Medicine Products: